Scarica l'app Stockscreener
17.99
7.12%
-1.38
Neurogene Inc Azioni (NGNE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 |
| Durata del periodo | 3 mesi | 3 mesi |
| Revenues |
100.00%
-
|
-2.968 |
Operating Expenses
|
40.97%
18.78
|
31.82 |
| Interest Income/Expense |
0.003
|
- |
| Operating Income/Loss |
40.97%
-18.78
|
-31.82 |
| Income/Loss From Continuing Operations Before Tax |
56.93%
-16.92
|
-39.28 |
| Income/Loss From Continuing Operations After Tax |
9.15%
-16.92
|
-15.50 |
|
Net Income/Loss
|
9.15%
-16.92
|
-15.50 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- |
| Attributable To Noncontrolling Interest |
-
|
- |
| Basic Average Shares |
16.90
|
- |
| Diluted Average Shares |
16.90
|
- |
| Basic Earnings Per Share |
-1.00
|
- |
| Diluted Earnings Per Share |
-1.00
|
- |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
1.54%
7.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):